SEROEPIDEMIOLOGY IN THE SURVEILLANCE OF VACCINE-PREVENTABLE DISEASES
Authors:
Open Access
- 28 April 2018
- journal article
- Published by Central Research Institute for Epidemiology in Journal of microbiology, epidemiology and immunobiology
- Vol. 95 (2) , 87-94
Abstract
Seroepidemiology is a potentially powerful tool for predicting and monitoring the effectiveness of specific prevention program using studies of antibody prevalence. The availability of a certified collection of blood serum (serum bank) allows to carry out a reliable assessment of population immunity to vaccine-preventable diseases; to determine the degree of epidemiological risk of the infection spread in various areas of the country; to implement short-term and long-term forecasting of changes in the situation on topical infections; to substantiate preventive measures in the system of biosafety for defined population groups and decreed contingents; to provide information necessary for making the optimal management decisions.Keywords
This publication has 7 references indexed in Scilit:
- Use of serological surveys to generate key insights into the changing global landscape of infectious diseaseThe Lancet, 2016
- A 16-year review of seroprevalence studies on measles and rubellaVaccine, 2016
- Seroepidemiology: an underused tool for designing and monitoring vaccination programmes in low‐ and middle‐income countriesTropical Medicine & International Health, 2016
- Estimating seroprevalence of vaccine-preventable infections: is it worth standardizing the serological outcomes to adjust for different assays and laboratories?Epidemiology and Infection, 2014
- The role of seroepidemiology in the comprehensive surveillance of vaccine-preventable diseasesCanadian Medical Association Journal, 2011
- "Herd Immunity": A Rough GuideClinical Infectious Diseases, 2011
- Ten years of serological surveillance in England and Wales: methods, results, implications and actionInternational Journal of Epidemiology, 2000